Short-term exposure to 50Hz ELF-EMF alters the cisplatin-induced oxidative response in AT478 murine squamous cell carcinoma cells

Bioelectromagnetics

Volumn 33, Issue 8, 2012, Pages 641-651

  Buldak, Rafal Jakub ^a   Polaniak, Renata ^a   Buldak, Lukasz ^a   Zwirska Korczala, Krystyna ^a   Skonieczna, Magdalena ^b   Monsiol, Aleksandra ^c   Kukla, Michal ^a   Dulawa Buldak, Anna ^a   Birkner, Ewa ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

^c UNIVERSITY OF SILESIA   (Poland)

Author keywords

Antioxidant enzymes; Cisplatin; DNA damage; Electromagnetic field; Lipid peroxidation

Indexed keywords

ANTIOXIDANTS; CELLS; CYTOLOGY; DAMAGE DETECTION; DNA; ENZYME ACTIVITY; LIPIDS; OXIDATION; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ENZYME ACTIVITY; ANTIOXIDANTS ENZYMES; CELL-BE; CELL/B.E; CIS-PLATIN; CISPLATIN; DNA DAMAGES; EXTREMELY LOW FREQUENCY ELECTROMAGNETIC FIELDS; LIPID PEROXIDATION; REACTIVE OXYGEN SPECIES;

ELECTROMAGNETIC FIELDS;

MURINAE; SOLENOIDEA;

ANTIOXIDANT; CISPLATIN; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTICLE; DNA DAMAGE; DRUG EFFECT; ELECTROMAGNETIC FIELD; ENZYMOLOGY; INTRACELLULAR SPACE; LIPID PEROXIDATION; METABOLISM; MOUSE; OXIDATIVE STRESS; PATHOLOGY; RADIATION EXPOSURE; SQUAMOUS CELL CARCINOMA; TIME; TUMOR CELL LINE;

ANIMALS; ANTIOXIDANTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CISPLATIN; DNA DAMAGE; ELECTROMAGNETIC FIELDS; INTRACELLULAR SPACE; LIPID PEROXIDATION; MALONDIALDEHYDE; MICE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 84868654485     PISSN: 01978462     EISSN: 1521186X     Source Type: Journal    
DOI: 10.1002/bem.21732     Document Type: Article

References (44)

1. Alexandre J, Nicco C, Chéreau C, Laurent A, Weill B, Goldwasser F, Batteux F. 2006. Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J Natl Cancer Inst 98(4): 236-244.
2. Aniolczyk H. 2000. Electromagnetic fields-Sources and impact, Vol. 1. Lodź, Poland: Oficyna Wydawnicza IMP. pp 243-260.
3. Attia SM. 2010. The impact of quercetin on cisplatin-induced clastogenesis and apoptosis in murine marrow cells. Mutagenesis 25(3): 281-288.
4. Azevedo RB, Lacava ZG, Miyasaka CK, Chaves SB, Curi R. 2001. Regulation of antioxidant enzyme activities in male and female rat macrophages by sex steroids. Braz J Med Biol Res 34(5): 683-687.
5. Bodnar L, Wcislo G, Szczylik C, Miedzińska-Maciejewska M. 2003. Renal nephroprotection during chemotherapy with platinum compounds in cancer patients. Wspolczesna Onkologia 7(9): 702-709.
6. Bosl GJ, Bajorin DF. 1994. Etopoxide plus carboplatin or cisplatin in good-risk patients with germ cell tumors: A randomized comparison. Semin Oncol 21(Suppl. 12): 61-64.
7. Chen G, Upham BL, Sun W, Chang CC, Rothwell EJ, Chen KM, Yamasaki H, Trosko JE. 2000. Effect of electromagnetic field exposure on chemically induced differentiation of friend erythroleukemia cells. Environ Health Perspect 108(10): 967-972.
8. Constantinou C, Hyatt JA, Vraka PS, Papas A, Papas KA, Neophytou C, Hadjivassiliou V, Constantinou AI. 2009. Induction of caspase-independent programmed cell death by vitamin E natural homologs and synthetic derivatives. Nutr Cancer 61(6): 864-874.
9. Davanipour Z, Sobel E. 2009. Long-term exposure to magnetic fields and the risks of Alzheimer's disease and breast cancer: Further biological research. Pathophysiology 16(2-3): 149-156.
10. De Mattei M, Caruso A, Traina GC, Pezzetti F, Baroni T, Sollazzo V. 1999. Correlation between pulsed electromagnetic fields exposure time and cell proliferation increase in human osteosarcoma cell lines and human normal osteoblast cells in vitro. Bioelectromagnetics 20(3): 177-182.
11. Di Loreto S, Falone S, Caracciolo V, Sebastiani P, D'Alessandro A, Mirabilio A, Zimmitti V, Amicarelli F. 2009. Fifty hertz extremely low-frequency magnetic field exposure elicits redox and trophic response in rat-cortical neurons. J Cell Physiol 219(2): 334-343.
12. Fatigoni C, Dominici L, Moretti M, Villarini M, Monarca S. 2005. Genotoxic effects of extremely low frequency (ELF) magnetic fields (MF) evaluated by the tradescantia-micronucleus assay. Environ Toxicol 20(6): 585-591.
13. Fruehauf JP, Meyskens FL, Jr. 2007. Reactive oxygen species: A breath of life or death? Clin Cancer Res 13(3): 789-794.
14. Garip AI, Akan Z. 2010. Effect of ELF-EMF on number of apoptotic cells; correlation with reactive oxygen species and HSP. Acta Biol Hung 61(2): 158-167.
15. Gupta A, Srivastava S, Prasad R, Natu SM, Mittal B, Negi MP, Srivastava AN. 2010. Oxidative stress in non-small cell lung cancer patients after chemotherapy: Association with treatment response. Respirology 15(2): 349-356.
16. 2-mediated oxidative stress. Free Radic Biol Med 48(8): 1024-1033.
17. Hagar JM, Hale SL, Ilvento JP, Kloner RA. 1991. Lack of significant effects of superoxide dismutase and catalase on development of reperfussion arrytmias. Basic Res Cardiol 86: 127-136.
18. Harris PA, Lamb J, Heaton B, Wheatley DN. 2002. Possible attenuation of the G2 DNA damage cell cycle checkpoint in HeLa cells by extremely low frequency (ELF) electromagnetic fields. Cancer Cell Int 2(1): 3.
19. IARC. 2002. Non-ionizing radiation. Part 1: Static and extremely low-frequency (ELF) electric and magnetic fields. IARC Monogr Eval Carcinog Risks Hum 80: 1-395.
20. Jajte J, Zmyslony M. 2000. The role of melatonin in the molecular mechanism of weak, static and extremely low frequency (50Hz) magnetic fields (ELF). Med Pr 51(1): 51-57.
21. Kim HJ, Lee JH, Kim SJ, Oh GS, Moon HD, Kwon KB, Park C, Park BH, Lee HK, Chung SY, Park R, So HS. 2010. Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity. J Neurosci 30(11): 3933-3946.
22. LeBel CP, Ischiropoulos H, Bondy SC. 1992. Evaluation of the probe 2′, 7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5(2): 227-231.
23. Li H, Zeng Q, Weng Y, Lu D, Jiang H, Xu Z. 2005. Effects of ELF magnetic fields on protein expression profile of human breast cancer cell MCF7. Sci China C Life Sci 48(5): 506-514.
24. Lindgren M, Gustavsson M, Hamnerius Y, Galt S. 2001. ELF magnetic fields in a city environment. Bioelectromagnetics 22(2): 87-90.
25. Miyasaka CK, de Souza JA, Torres RP, Filho JM, Lajolo FM, Curi R. 1998. Effect of the administration of fish oil by gavage on activities of antioxidant enzymes of rat lymphoid organs. Gen Pharmacol 30(5): 759-762.
26. Muller A, Cadenas E, Graf P, Sies H. 1984. A novel biologically active seleno-organic compound-I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen). Biochem Pharmac 33: 3235-3239.
27. Newman DJ, Cragg GM, Snader KM. 2003. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66(7): 1022-1037.
28. Oberley LW, Buettner GR. 1979. Role of superoxide dismutase in cancer: A review. Cancer Res 39: 1141-1149.
29. Olive PL. 2002. The comet assay. An overview of techniques. Methods Mol Biol 203: 179-194.
30. Ostrovidov S, Franck P, Joseph D, Martarello L, Kirsch G, Belleville F, Nabet P, Dousset B. 2000. Screening of new antioxidant molecules using flow cytometry. J Med Chem 43(9): 1762-1769.
31. Paduch R, Rzeski W, Klatka J. 2009. The effect of cisplatin on human larynx carcinoma cell motility. Folia Histochem Cytobiol 47(1): 75-79.
32. Paglia DE, Valentine WN. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70(1): 158-169.
33. Paoletti F, Aldinncci D, Mocali A. 1986. A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. Anal Biochem 154: 526-541.
34. Placer ZA, Cushman LL, Johnson BC. 1966. Estimation of product of lipid peroxidation (malondialdehyde) in biochemical systems. Anal Biochem 16: 359-364.
35. Polaniak R, Buldak RJ, Karoń M, Birkner K, Kukla M, Zwirska-Korczala K, Birkner E. 2010. Influence of an extremely low frequency magnetic field (ELF-EMF) on antioxidative vitamin E properties in AT478 murine squamous cell carcinoma culture in vitro. Int J Toxicol 29(2): 221-230.
36. Pratibha R, Sameer R, Rataboli PV, Bhiwgade DA, Dhume CY. 2006. Enzymatic studies of cisplatin-induced oxidative stress in hepatic tissue of rats. Eur J Pharmacol 532(3): 290-293.
37. Simkó M, Kriehuber R, Weiss DG, Luben RA. 1998. Effects of 50Hz EMF exposure on micronucleus formation and apoptosis in transformed and nontransformed human cell lines. Bioelectromagnetics 19(2): 85-91.
38. Tachibana A, Nagasawa A, Kitamura A, Miyazaki S, Murase K. 2010. Experimental verification of age-dependent cisplatin-induced nephrotoxicity in rats using dynamic contrast-enhanced computed tomography. Jpn J Radiol 28(2): 123-131.
39. Trachootham D, Alexandre J, Huang P. 2009. Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach? Nat Rev Drug Discov 8(7): 579-591.
40. Villarini M, Moretti M, Scassellati-Sforzolini G, Boccioli B, Pasquini R. 2006. Effects of co-exposure to extremely low frequency (50Hz) magnetic fields and xenobiotics determined in vitro by the alkaline comet assay. Sci Total Environ 361(1-3): 208-219.
41. Wolf FI, Torsello A, Tedesco B, Fasanella S, Boninsegna A, D'Ascenzo M, Grassi C, Azzena GB, Cittadini A. 2005. 50Hz extremely low frequency electromagnetic fields enhance cell proliferation and DNA damage: Possible involvement of a redox mechanism. Biochim Biophys Acta 1743(1-2): 120-129.
42. Yoo DR, Chong SA, Nam MJ. 2009. Proteome profiling of arsenic trioxide-treated human hepatic cancer cells. Cancer Genomics Proteomics 6(5): 269-274.
43. Zwirska-Korczala K, Adamczyk-Sowa M, Polaniak R, Sowa P, Birkner E, Drzazga Z, Brzozowski T, Konturek SJ. 2004. Influence of extremely-low-frequency magnetic field on antioxidative melatonin properties in AT478 murine squamous cell carcinoma culture. Biol Trace Elem Res 102(1-3): 227-243.
44. Zwirska-Korczala K, Jochem J, Adamczyk-Sowa M, Sowa P, Polaniak R, Birkner E, Latocha M, Pilc K, Suchanek R. 2005. Effect of extremely low frequency of electromagnetic fields on cell proliferation, antioxidative enzymes activities and lipid peroxidation in 3T3-L1 preadipocytes-An in vitro study. J Physiol Pharmacol 56(Suppl. 6): 101-108.